样式: 排序: IF: - GO 导出 标记为已读
-
Circ_0087851 suppresses colorectal cancer malignant progression through triggering miR-593-3p/BAP1-mediated ferroptosis J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-04-20 Ming Huang, Ting Gao, Xianyong Chen, Junlei Yi, Xuan Zhou
-
Characteristics and outcomes of cancer patients admitted to intensive care units in cancer specialized hospitals in China J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-04-20 Wensheng Liu, Dongmin Zhou, Li Zhang, Mingguang Huang, Rongxi Quan, Rui Xia, Yong Ye, Guoxing Zhang, Zhuping Shen
Purpose Standard intensive care unit (ICU) admission policies and treatment strategies for patients with cancer are still lacking. To depict the current status of admission, characteristics, and outcomes of patients with cancer in the ICU. Methods A multicenter cross-sectional study was performed from May 10, 2021 to July 10, 2021, in the ICU departments of 37 cancer-specialized hospitals in China
-
Necroptosis-related lncRNA-based novel signature to predict the prognosis and immune landscape in soft tissue sarcomas J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-04-18 Qiuzhong Long, Zhengtian Li, Wenkang Yang, Ke Huang, Gang Du
-
Imaging for local recurrence of breast cancer J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-04-17 T. Schlaiss, L. Bott, S.-L. Herbert, C. Bartmann, M. Kiesel, J. Salmen, S. T. Sauer, S. A. Christner, B. Petritsch, J.-P. Grunz, A. Woeckel, S. Löb, J. Diessner
-
Artesunate attenuates the tumorigenesis of choroidal melanoma via inhibiting EFNA3 through Stat3/Akt signaling pathway J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-04-17 Ningning Yao, Qingyue Ma, Wendan Yi, Yuanzhang Zhu, Yichong Liu, Xiaodi Gao, Qian Zhang, Wenjuan Luo
-
Utilization of sperm cryopreservation in patients with testicular cancer J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-04-17 Viktoria Menzel, Emilia Richter, Charlotte Helke, Björn Thorben Bürk, Holger H. H. Erb, Steffen Leike, Angelika Borkowetz, Christian Thomas, Martin Baunacke
Purpose We assessed factors that affect the utilization of sperm cryopreservation before 2021, when patients covered expenses, and the influence on quality of life. Methods Between 2011 and 2021, testicular cancer survivors (TCS) at our clinic completed a questionnaire, including EORTC QLQ-TC26, covering sperm cryopreservation, sociodemographic details, post-treatment births, and artificial insemination
-
Identification and validation of a lactate metabolism-related six-gene prognostic signature in intrahepatic cholangiocarcinoma J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-04-16 Chen Sang, Li Yan, Jian Lin, Youpei Lin, Qiang Gao, Xia Shen
-
Platinum-based adjuvant chemoradiotherapy versus adjuvant radiotherapy in patients with head and neck adenoid cystic carcinoma J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-04-16 Zichen Qiu, Zheng Wu, Xiong Zhou, Minchuan Lin, Yong Su, Yalan Tao
-
Construction and validation of a folate metabolism-related gene signature for predicting prognosis in HNSCC J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-04-16 Lu Wang, Ye He, Yijiang Bai, Shuai Zhang, Bo Pang, Anhai Chen, Xuewen Wu
-
USP7 promotes cervical cancer progression by stabilizing MTDH expression through deubiquitination J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-04-16 Na Wang, Jing Xu, Yujing Wang, Xuejiao Zhang, Hongzhen Zhang
-
zDHHC3-mediated S-palmitoylation of SLC9A2 regulates apoptosis in kidney clear cell carcinoma J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-04-15 Xiuyun Zhang, Junpeng Hou, Guangyuan Zhou, Haixia Wang, Zeang Wu
-
Minimal residual disease in systemic light chain amyloidosis: a systematic review and meta-analysis J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-04-15 Xuefeng Li, Yan Yu, Hongbin Yu, Mengran Chen, Xin Zhang, Yu Wu
-
The role of histological subtype and chemotherapy on prognosis of ureteral cancer J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-04-13 Jincong Li, Yuxuan Song, Yun Peng, Jiaxing Lin, Yiqing Du, Caipeng Qin, Tao Xu
-
Utilization and quality of palliative care in patients with hematological and solid cancers: a population-based study J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-04-12 Cordula Gebel, Bianka Ditscheid, Franziska Meissner, Ekaterina Slotina, Isabel Kruschel, Ursula Marschall, Ullrich Wedding, Antje Freytag
-
Unmet supportive care needs among cancer patients: exploring cancer entity-specific needs and associated factors J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-04-12 Franziska Springer, Anja Mehnert-Theuerkauf, Claudia Gebhardt, Jens-Uwe Stolzenburg, Susanne Briest
-
Oral arsenic plus imatinib versus imatinib solely for newly diagnosed chronic myeloid leukemia: a randomized phase 3 trial with 5-year outcomes J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-04-11 Jie Tian, Yong-Ping Song, Gao-Chong Zhang, Shu-Fang Wang, Xiao-Xiang Chu, Ye Chai, Chun-Ling Wang, Ai-Li He, Feng Zhang, Xu-Liang Shen, Wei-Hua Zhang, Lin-Hua Yang, Da-Nian Nie, Dong-Mei Wang, Huan-Ling Zhu, Da Gao, Shi-Feng Lou, Ze-Ping Zhou, Guo-Hong Su, Yan Li, Jin-Ying Lin, Qing-Zhi Shi, Gui-Fang Ouyang, Hong-Mei Jing, Sai-Juan Chen, Jian Li, Jian-Qing Mi
-
Diagnostic performance of non-invasive liver fibrosis scores in patients with early-intermediate hepatocellular carcinoma J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-04-11 Christopher Schrecker, Falko Schulze, Jörg Trojan, Wolf Otto Bechstein, Stefan Zeuzem, Christine Koch
-
Prognostic and onco-immunological value of immune-related eRNAs-driven genes in lung adenocarcinoma J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-04-11 Xuan Wu, Xingru Zhao, Chao Zhou, Nan Wei, Zhiwei Xu, Xiaoju Zhang
-
Impact of concurrent medications on clinical outcomes of cancer patients treated with immune checkpoint inhibitors: analysis of Health Insurance Review and Assessment data J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-04-10 Soojung Hong, Ju Hyun Lee, Ja Yoon Heo, Koung Jin Suh, Se Hyun Kim, Yu Jung Kim, Jee Hyun Kim
-
Preoperative nomogram for predicting spread through air spaces in clinical-stage IA non-small cell lung cancer using 18F-fluorodeoxyglucose positron emission tomography/computed tomography J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-04-10 Yun Wang, Deng Lyu, Chao Cheng, Taohu Zhou, Wenting Tu, Yi Xiao, Changjing Zuo, Li Fan, Shiyuan Liu
-
Research advances of tissue-derived extracellular vesicles in cancers J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-04-10 Wei Li, Jingyao Zhu, Jiayuan Li, Yiyun Jiang, Jiuai Sun, Yan Xu, Hongzhi Pan, Yan Zhou, Jun Zhu
-
Advanced renal cell carcinoma management: the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG) consensus update J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-04-09 Andrey Soares, Fernando Sabino Marques Monteiro, Karine Martins da Trindade, Adriano Gonçalves e Silva, Ana Paula Garcia Cardoso, André Deeke Sasse, André P. Fay, André Paternò Castello Dias Carneiro, Antonio Machado Alencar Junior, Augusto César de Andrade Mota, Bruno Santucci, Daniel da Motta Girardi, Daniel Herchenhorn, Daniel Vilarim Araújo, Denis Leonardo Jardim, Diogo Assed Bastos, Diogo Rodrigues
Purpose Renal cell carcinoma is an aggressive disease with a high mortality rate. Management has drastically changed with the new era of immunotherapy, and novel strategies are being developed; however, identifying systemic treatments is still challenging. This paper presents an update of the expert panel consensus from the Latin American Cooperative Oncology Group and the Latin American Renal Cancer
-
Comparison of the efficacy of enfortumab vedotin between patients with metastatic urothelial carcinoma who were treated with avelumab or pembrolizumab: real-world data from a multi-institutional study in Japan J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-04-09 Yosuke Hirasawa, Takahiro Adachi, Takeshi Hashimoto, Wataru Fukuokaya, Yuhei Koike, Yuji Yata, Kazumasa Komura, Taizo Uchimoto, Takuya Tsujino, Kazuki Nishimura, Kiyoshi Takahara, Masanobu Saruta, Kazutoshi Fujita, Mamoru Hashimoto, Hirotsugu Uemura, Ryoichi Shiroki, Takashi Azuma, Takahiro Kimura, Yoshio Ohno
-
Role of plasma EBV-DNA load and EBER status on newly diagnosed peripheral T-cell lymphoma J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-04-08 Jing Chen, Jie Zhou, Fei Cheng, Donghe Chen, Fangshu Guan, Enfan Zhang, Jingsong He, Zhen Cai, Yi Zhao
-
Safety and clinical efficacy of immune checkpoint inhibitors in advanced gastric cancer in the real world J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-04-08 Wen Hao, Wenjing Liu, Ruimin Chang, Mi Yang, Kai Xin, Jingxin Liu, Yibing Wang, Meijin Ren, Jiaqi Xie, Yang Yang
-
Long non-coding RNA RAD51-AS1 promotes the tumorigenesis of ovarian cancer by elevating EIF5A2 expression J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-04-07 Lu Zhao, Jia Huang, Wenting Liu, Xiaoyan Su, Bei Zhao, Xianggang Wang, Xiaoju He
-
Effect of acute inflammatory reaction induced by biopsy on tumor microenvironment J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-04-05 Yuanyuan Chen, Hualian Liu, Yadong Sun
-
Prognostic utility and characteristics of MIB-1 labeling index as a proliferative activity marker in childhood low-grade glioma: a retrospective observational study J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-04-05 David Gorodezki, Julian Zipfel, Andrea Bevot, Thomas Nägele, Martin Ebinger, Martin U. Schuhmann, Jens Schittenhelm
-
Clinicopathological factors predict residual lymph node metastasis in locally advanced rectal cancer with ypT0-2 after neoadjuvant chemoradiotherapy J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-04-04 Yujun Cui, Maxiaowei Song, Jian Tie, Shuai Li, Hongzhi Wang, Yangzi Zhang, Jianhao Geng, Zhiyan Liu, Huajing Teng, Xin Sui, Xianggao Zhu, Yong Cai, Yongheng Li, Weihu Wang
-
Development of postoperative bronchopleural fistula after neoadjuvant immunochemotherapy in non-small cell lung cancer: case reports and review of the literature J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-04-04 Renshan Zhao, Xiaomin Guan, Peng Zhang, Yunpeng Liu, Yinghui Xu, Chao Sun, Shi Qiu, Wenhao Zhu, Zhiguang Yang, Xu Wang
Background The advent of immune checkpoint inhibitors has dramatically changed the treatment paradigm for advanced non-small-cell lung cancer (NSCLC). Due to the complexity and diversity of stage III disease, the inclusion of immune checkpoint inhibitors (ICIs) in neoadjuvant treatment regimens is also required. However, immune-related adverse events (irAEs) limit the application of ICIs to a certain
-
An algorithm-based technique for counting mitochondria in cells using immunohistochemical staining of formalin-fixed and paraffin-embedded sections J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-04-03 Mai Sakashita, Noriko Motoi, Gaku Yamamoto, Emi Gambe, Masanori Suzuki, Yukihiro Yoshida, Shun-ichi Watanabe, Yutaka Takazawa, Kazunori Aoki, Atsushi Ochiai, Shingo Sakashita
Purpose Visualizing mitochondria in cancer cells from human pathological specimens may improve our understanding of cancer biology. However, using immunohistochemistry to evaluate mitochondria remains difficult because almost all cells contain mitochondria and the number of mitochondria per cell may have important effects on mitochondrial function. Herein, we established an objective system (Mito-score)
-
Association of preoperative sarcopenia with the long-term prognosis of patients with bladder cancer undergoing radical cystectomy J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-04-03 Sangmin Lee, Youngjoon Yoon, Jungyo Suh, Dalsan You, Bumsik Hong, Jun Hyuk Hong, Hanjong Ahn, In Gab Jeong, Bumjin Lim
Purpose This retrospective study aimed to assess the correlation between preoperative sarcopenia and long-term oncologic outcomes in patients undergoing radical cystectomy for bladder cancer. Methods We included 528 patients who underwent radical cystectomy for bladder cancer between 2000 and 2010 at Asan Medical Center, Seoul, Korea. Preoperative skeletal muscle mass was quantified by analyzing computed
-
Prognostic impact of metabolic syndrome in patients with primary endometrial cancer: a retrospective bicentric study J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-04-03 Ina Shehaj, Slavomir Krajnak, Morva Tahmasbi Rad, Bahar Gasimli, Annette Hasenburg, Thomas Karn, Marcus Schmidt, Volker Müller, Sven Becker, Khayal Gasimli
Purpose Endometrial cancer (EC) is the most common gynaecological cancer. Its incidence has been rising over the years with ageing and increased obesity of the high-income countries’ populations. Metabolic syndrome (MetS) has been suggested to be associated with EC. The aim of this study was to assess whether MetS has a significant impact on oncological outcome in patients with EC. Methods This retrospective
-
Identification and validation of tryptophan metabolism-related lncRNAs in lung adenocarcinoma prognosis and immune response J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-04-01 Mingjun Gao, Mengmeng Wang, Yong Chen, Jun Wu, Siding Zhou, Wenbo He, Yusheng Shu, Xiaolin Wang
Background Tryptophan (Trp) is an essential amino acid. Increasing evidence suggests that tryptophan metabolism plays a complex role in immune escape from Lung adenocarcinoma (LUAD). However, the role of long non-coding RNAs (lncRNAs) in tryptophan metabolism remains to be investigated. Methods This study uses The Cancer Genome Atlas (TCGA)-LUAD dataset as the training cohort, and several datasets
-
Prospects of molecular hydrogen in cancer prevention and treatment J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-03-31
Abstract Gas signaling molecules, including carbon monoxide (CO), nitric oxide (NO), and hydrogen sulfide (H2S), have been shown to have cancer therapeutic potential, pointing to a new direction for cancer treatment. In recent years, a series of studies have confirmed that hydrogen (H2), a weakly reductive gas, also has therapeutic effects on various cancers and can mitigate oxidative stress caused
-
Correction: Co-expression of DDR2 and IFITM1 promotes breast cancer cell proliferation, migration and invasion and inhibits apoptosis J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-03-28 Chenlu Wu, Jiafei Ying, Mei Dai, Jing Peng, Danhua Zhang
-
Development of a nomogram to predict the prognosis of patients with secondary bone tumors in the intensive care unit: a retrospective analysis based on the MIMIC IV database J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-03-28 Weikang Li, Jinliang Li, Jinkui Cai
-
Urocortin-1 promotes colorectal cancer cell migration and proliferation and inhibits apoptosis via inhibition of the p53 signaling pathway J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-03-28
Abstract Purpose To investigate the effect of urocortin-1 (UCN-1) on growth, migration, and apoptosis in colorectal cancer (CRC) in vivo and vitro and the mechanism by which UCN-1 modulates CRC cells in vitro. Methods The correlation between UCN-1 and CRC was evaluated using The Cancer Genome Atlas (TCGA) database and a tissue microarray. The expression of UCN-1 in CRC cells was assessed using quantitative
-
Resveratrol ameliorates glioblastoma inflammatory response by reducing NLRP3 inflammasome activation through inhibition of the JAK2/STAT3 pathway J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-03-28 Chao Zhang, Qian Peng, Yuhang Tang, Chengcheng Wang, Shuai Wang, Dong Yu, Shiqiang Hou, Yu Wang, Lanlan Zhang, Ning Lin
-
Enzyme-labeled liquid-based cytology (ELLBC): a new noninvasive diagnostic method for bladder cancers J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-03-28 Chao Jiang, Xiang Li, Ruilong Chen, Yongliu Yang, Yi Wang
-
Overexpression of Transmembrane Phosphatase with Tensin homology (TPTE) in prostate cancer is clinically significant, suggesting its potential as a valuable biomarker J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-03-28
Abstract Purpose Cancer testis antigens (CTAs) are a family of proteins typically expressed in male testicles but overexpressed in various cancer cell types. Transmembrane Phosphatase with Tensin homology (TPTE) is expressed only in the testis of healthy individuals and is a member of the family of CTAs. The current study, for the first time, examined the significance of TPTE expression in prostate
-
Decision regret of cancer patients after radiotherapy: results from a cross-sectional observational study at a large tertiary cancer center in Germany J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-03-28 Alexander Rühle, Leonie Wieland, Andreas Hinz, Anja Mehnert-Theuerkauf, Nils H. Nicolay, Clemens Seidel
-
Does the time interval from neoadjuvant camrelizumab combined with chemotherapy to surgery affect outcomes for locally advanced esophageal squamous cell carcinoma? J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-03-27 Jiacong Liu, Linhai Zhu, Xuhua Huang, Zhongjie Lu, Yanye Wang, Yuhong Yang, Jiayue Ye, Chen Gu, Wang Lv, Chong Zhang, Jian Hu
-
BRAF/MEK-targeted therapy in BRAF ex15 p.T599dup mutation-driven NSCLC: a case report J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-03-27 Lan Jiang, Pirong Yang, Yufeng Liu, Juan Li
-
Symptom burden and relief in palliative care units of German Comprehensive Cancer Center and other hospitals J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-03-27
Abstract Purpose The National Hospice and Palliative Registry contains patient data from German hospice and palliative care facilities about symptoms. The aim of the study at hand is to differentiate symptom burden of patients in palliative care units between Comprehensive Cancer Center (CCC) and other hospitals regarding symptom burden and relief of patients in palliative care units. Methods The registry
-
Chemotherapy-initiated cysteine-rich protein 61 decreases acute B-lymphoblastic leukemia chemosensitivity J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-03-26 Pengchong Shi, Zhen Lin, Yanfang Song, Zhaozhong Li, Menglu Zeng, Li Luo, Yingping Cao, Xianjin Zhu
-
Risk of HBV reactivation in HCC patients undergoing combination therapy of PD-1 inhibitors and angiogenesis inhibitors in the antiviral era J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-03-26 Rui Wang, Guili Tan, Dingjia Lei, Yadi Li, JiaoJiao Gong, Yao Tang, Hao Pang, Huating Luo, Bo Qin
-
Alteration of serum bile acid profiles of HBV-related hepatocellular carcinoma identified by LC–MS/MS J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-03-25
Abstract Background Hepatocellular carcinoma closely related to metabolic disorders is a common and aggressive liver malignancy. The dysregulation of bile acid homeostasis has emerged as a key factor for the development and progression of HCC. We aimed to investigate the relationship between bile acids and HCC diagnosis and progression. Methods A total of 744 HBV-related patients (including 396 HCC
-
Osteopontin promotes tumor growth and metastasis and GPX4-mediated anti-lipid peroxidation in triple-negative breast cancer by activating the PI3k/Akt/mTOR pathway J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-03-25 Man Guo, Mengyue Liu, Weihan Li, Cao Wang, Lu Zhang, Hao Zhang
-
Disulfidptosis features and prognosis in head and neck squamous cell carcinoma patients: unveiling and validating the prognostic signature across cohorts J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-03-25
Abstract Background Head and neck squamous cell carcinoma (HNSCC) is a significant health concern with a variable global incidence and is linked to regional lifestyle factors and HPV infections. Despite treatment advances, patient prognosis remains variable, necessitating an understanding of its molecular mechanisms and the identification of reliable prognostic biomarkers. Methods We analyzed 959 HNSCC
-
The cross talk of ubiquitination and chemotherapy tolerance in colorectal cancer J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-03-23
Abstract Ubiquitination, a highly adaptable post-translational modification, plays a pivotal role in maintaining cellular protein homeostasis, encompassing cancer chemoresistance-associated proteins. Recent findings have indicated a potential correlation between perturbations in the ubiquitination process and the emergence of drug resistance in CRC cancer. Consequently, numerous studies have spurred
-
Secondary solid malignancies and precancerous lesions after allogeneic hematopoietic stem cell transplantation using non-total body irradiation-based conditioning in acute myeloid leukemia J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-03-22 Gruber Isabella, Appel Katharina, Edinger Matthias, Koelbl Oliver, Wolff Daniel
-
Analyzing the associations between tertiary lymphoid structures and postoperative prognosis, along with immunotherapy response in gastric cancer: findings from pooled cohort studies J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-03-22 Haoxin Peng, Xiangrong Wu, Cheng Zhang, Yueting Liang, Siyuan Cheng, Honglang Zhang, Lin Shen, Yang Chen
-
Identification roles of NFE2L3 in digestive system cancers J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-03-22 Fan Li, Zhili Wen
-
Predicting pathological complete response to neoadjuvant chemotherapy in breast cancer patients: use of MRI radiomics data from three regions with multiple machine learning algorithms J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-03-21 Guangying Zheng, Jiaxuan Peng, Zhenyu Shu, Hui Jin, Lu Han, Zhongyu Yuan, Xue Qin, Jie Hou, Xiaodong He, Xiangyang Gong
-
Integrative analysis with machine learning identifies diagnostic and prognostic signatures in neuroblastoma based on differentially DNA methylated enhancers between INSS stage 4 and 4S neuroblastoma J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-03-21
Abstract Introduction Accumulating evidence demonstrates that aberrant methylation of enhancers is crucial in gene expression profiles across several cancers. However, the latent effect of differently expressed enhancers between INSS stage 4S and 4 neuroblastoma (NB) remains elusive. Methods We utilized the transcriptome and methylation data of stage 4S and 4 NB patients to perform Enhancer Linking
-
Identification and validation of neutrophils-related subtypes and prognosis model in triple negative breast cancer J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-03-21 Shanqi Li, Yuzhou Qian, Wanchen Xie, Xinyu Li, Jiaying Wei, Long Wang, Guosheng Ren, Xuedong Yin
-
Pan-cancer analysis of DDIT4 identifying its prognostic value and function in acute myeloid leukemia J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-03-20 Fangmei Li, Jiyu Miao, Rui Liu, Ru Zhang, Aili He
-
A CT-based radiomics nomogram involving the cystic fluid area for differentiating appendiceal mucinous neoplasms from appendicitis with intraluminal fluid J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-03-20
Abstract Objective To develop and validate a radiomics nomogram based on computed tomography (CT) to distinguish appendiceal mucinous neoplasms (AMNs) from appendicitis with intraluminal fluid (AWIF). Method A total of 211 patients from two medical institutions were retrospectively analysed, of which 109 were pathologically confirmed as having appendicitis with concomitant CT signs of intraluminal
-
Preoperative ultrasound-guided dual localization with titanium clips and carbon nanoparticles for predicting the surgical approach and guiding the resection of Siewert type II esophagogastric junction adenocarcinoma J. Cancer Res. Clin. Oncol. (IF 3.6) Pub Date : 2024-03-20
Abstract Objective To investigate the superiority of preoperative ultrasound-guided titanium clip and nanocarbon dual localization over traditional methods for determining the surgical approach and guiding resection of Siewert type II adenocarcinoma of the esophagogastric junction (AEG). Method This study included 66 patients with Siewert type II AEG who were treated at the PLA Joint Logistics Support